Hisamitsu America Company Profile

16:46 EDT 22nd June 2018 | BioPortfolio

News Articles [94 Associated News Articles listed on BioPortfolio]

Hisamitsu totes positive Phase III data for transdermal PD therapy

Tosu, Japan-based Hisamitsu Pharmaceutical has released positive Phase III data from its trial of a transdermal…

Hisamitsu's HP-3070 meets in Phase III for schizophrenia

Hisamitsu Pharmaceutical Co., Ltd. 2018 Q3 - Results - Earnings Call Slides

Noven Announces Successful Resolution of FDA Warning Letter

Noven Pharmaceuticals, Inc. announced today that it has received a close-out letter from the U.S. Food and Drug Administration (FDA) lifting a 2016 Warning Letter related to its M...

Notification of the Results of the Phase III Clinical Study of HP-3070 (Transdermal Patch for the Treatment of Schizophrenia) in the U.S.

Hisamitsu Pharmaceutical Co., Ltd. (Headquarters: Tosu City, Saga Prefecture, President and Chief Executive Officer (CEO): Hirotaka Nakatomi (hereinafter "Hisamitsu Pharmaceutical...

Notification of the Results of the Phase III Clinical Study of HP-3070 (Transdermal Patch for the Tr

Notification of the Results of the Phase III Clinical Study of HP-3070 (Transdermal Patch for the Treatment of Schizophrenia) in the U.S. January 31, 2018 09:00 AM Eastern Standard Time MIAMI...

Global and North America Pain Relief Patches Market Status and Future Forecast 20132023 [Report Updated: 06022018] Prices from USD $2500

SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPar...

Transdermal patch for treatment of schizophrenia hits Phase III goals

Japanese drugmaker Hisamitsu Pharmaceuticals, along with US subsidiary Noven Pharmaceuticals, say their…

PubMed Articles [521 Associated PubMed Articles listed on BioPortfolio]

The Paleo-Indian Entry into South America According to Mitogenomes.

Recent and compelling archaeological evidence attests to human presence ∼14.5 thousand years ago (Kya) at multiple sites in South America and a very early exploitation of extreme high-altitude Andea...

The status of cryptococcosis in Latin America.

Cryptococcosis is a life-threatening fungal infection caused by the encapsulated yeasts Cryptococcus neoformans and C. gattii, acquired from the environment. In Latin America, as occurring worldwide, ...

Analysis of ophthalmological and vision-related publications in Latin America.

To assess scientific production related to ophthalmology and vision in Latin America during the period from 2006 to 2015.

Obesity and hypertension in Latin America: Current perspectives.

In the countries of Central America, South America and the Caribbean, there has been a dramatic rise in obesity, the metabolic syndrome, hypertension and other cardiovascular risk factors in the last ...

First report of the post-fire morel Morchella exuberans in eastern North America.

Reports of true morels (Morchella) fruiting on conifer burn sites are common in western North America where five different fire-adapted species of black morels (Elata Clade) have been documented based...

Clinical Trials [346 Associated Clinical Trials listed on BioPortfolio]

Improving Perinatal Care in Latin America

Many obstetrical interventions used in Latin America, as in other parts of the world, have been shown to be ineffective or harmful, while effective interventions remain underutilized. This...

Efficacy of NovoSeven® in Bleeding Prophylaxis in Hemophilia

This trial is conducted in Africa, Asia, Europe, South America, and the United States of America (USA). The purpose of this study is to evaluate the effectiveness of secondary prophylacti...

Scaling Up Science-based Mental Health Interventions in Latin America

Conduct systematic, multi-site mental health implementation research in both rural and urban primary care settings with a broad group of stakeholders in the US and Latin America.

Use of Activated Recombinant Human Factor VII in Cardiac Surgery

This trial is conducted in Africa, Asia, Europe, South America and the United States of America (USA). The trial is planned to investigate the safety and efficacy of NovoSeven® in the ma...

Comparison of NN1250 With Sitagliptin in Subjects With Type 2 Diabetes Never Treated With Insulin

This trial will be conducted in Africa, Asia, North America and South America. The aim of this clinical trial is to compare NN1250 with sitagliptin, as add-on to subject's own current oral...

Companies [908 Associated Companies listed on BioPortfolio]

Hisamitsu America, Inc.

Hisamitsu America

Hisamitsu Pharmaceutical Co., Inc.

Fagron North America

Fagron North America is a group of innovative, scientific pharmaceutical companies that focus on optimizing and innovating pharmaceutical compounding across the U.S. Fagron North ...

JMS North America Corporation

JMS North America (JMSNA) was established as a wholly owned subsidiary of JMS Co., Ltd., one of the largest Japanese medical device companies, in March 1993. Now JMSNA's headquarters is located in Hay...

More Information about "Hisamitsu America" on BioPortfolio

We have published hundreds of Hisamitsu America news stories on BioPortfolio along with dozens of Hisamitsu America Clinical Trials and PubMed Articles about Hisamitsu America for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Hisamitsu America Companies in our database. You can also find out about relevant Hisamitsu America Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record